Navigation Links
Sirtris' review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
Date:10/1/2008

CAMBRIDGE, MA [October 1, 2008] Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it published a new review article on the growing body of sirtuin research and its potential to treat diseases of aging such as Type 2 Diabetes, mitochondrial disorders, inflammation, cancer, and heart disease. Entitled "SIRTUINS Novel Therapeutic Targets to Treat Age-Associated Diseases," the review appears in today's issue of the journal Nature Reviews Drug Discovery.

Sirtuins are a family of enzymes which target genes that control aging. There are a total of seven sirtuin enzymes that exist in mammals. SIRT1 is the founding member of this class of enzymes and is currently the most studied of the group. When activated, SIRT1 appears to mimic some of the positive health effects seen in calorie-restricted animals.

"We are excited to be at the forefront of this research, which continues to intensify as we see positive results from early human clinical studies," said Christoph Westphal, M.D., Ph.D., Chief Executive Officer of Sirtris, a GSK company. "The body of clinical data supporting the role of SIRT1 activation as a viable mechanism for treating a broad range of diseases of metabolism and aging is growing."

Peter Elliott, Ph.D., Senior Vice President of Development, said, "At Sirtris, we are targeting the genes which control the aging process with the potential to treat diseases of aging such as diabetes, neurodegeneration, cancer, and inflammation."

This review highlights the molecular mechanism of action of sirtuins with a view towards diseases where SIRT1 activation shows therapeutic promise. Such diseases of aging include Type 2 Diabetes and mitochondrial disorders, cardiovascular disease, cancer, neurodegeneration and inflammatory diseases. One of the first small molecules discovered to exhibit the positive effec
'/>"/>

Contact: Caton Lovett
caton@purecommunicationsinc.com
910-509-3975
Pure Communications Inc.
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology news :

1. Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
2. Review article provides tools for the Rosaceae genomics community
3. Medicines derived from cannabis: a review of adverse events
4. Stanford researchers publish review of US medical device regulation
5. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
6. CU-Boulder, biotech firm team up on python project in search for human cardiac therapeutics
7. Michael J. Fox Foundation PD Therapeutics Conference
8. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
9. Iron-moving malfunction may underlie neurodegenerative diseases, aging
10. Gaining a better understanding of kidney diseases
11. Biodegradable polymers show promise for improving treatment of acute inflammatory diseases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...ococcus Aureus ) and other drug-resistant bacteria... prototype devices have been developed to offer sa...ls. , Two prototype devices have been developed:....g. hands and feet) in hospitals and public spaces...her to shoot bacteria-killing agents into infested...
(Date:11/25/2009)...l Death Research Laboratory in the University of H... prestigious Johnson & Johnson Focused Funding gra...ell damage in Parkinson,s disease. The award, whic... innovation and excellence in science, was announc...month at an event at the Hyatt Regency Hotel in Ne...
(Date:11/24/2009)...rescribed by traditional healers in Brazil to trea...ain to fever and flu. , Now for the first time, r...to scientifically prove the pain relieving propert...ian mint. , Testing this ancient South American h...ocha was able to show that when prepared as a ,tea...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering 6063 1Prevention experts urge modification to 2009 H1N1 guidance for health care workers 60874 1Prevention experts urge modification to 2009 H1N1 guidance for health care workers 60874 2Ants are friendly to some trees but not others 10648 1Ants are friendly to some trees but not others 10648 2
...urring more frequently than at any time in the las...lian-based scientists. , Investigations by Associa...xcellence in Coral Reef Studies and The University...uinea show how often the reefs were ‘wiped out?by ...nd was in stark contrast to what we see in the mod...
...rvation Society (WCS) and U.S. Geological Survey (...un national parks lose nearly a quarter of their p...ality, yet their numbers remain stable due to a co...prey. The study, which appears in the journal Eco...d areas with high prey densities in an overall tig...
...pears that nature prefers to build its proteins ar...ning advanced computational modeling and cutting-e...iversity and Baylor College of Medicine suggests t...e parts that fold first. , The findings appear i... Nature refuses to choose between form and functio...
Other Biology News:Coral stress 'like never in history' 2Wild tigers need cat food 2Protein folding: Building a strong foundation 2
(Date:11/30/2009)...wire-FirstCall/ -- BioMarin Pharmaceutical Inc. (N...rug Administration (FDA) has granted orphan drug d...ampridine phosphate, for the rare autoimmune disea...DAP has previously received orphan drug designatio...e for Medicinal Products for Human Use of the Euro...
(Date:11/30/2009)...Newswire-Asia/ -- WuXi PharmaTech (NYSE: WX ), a...l-device research and,development outsourcing comp...,announced that it had been selected to the Deloi...th consecutive year. The list recognizes the 50,fa...ia, and telecommunications,industries based on rev...
(Date:11/28/2009)...onal Advisory Committee on Climate Change (NACCC) ...oject in collaboration with the Vanuatu Meteorolog...have generated preliminary climate change and sea ...or the country’s SNC reporting to the United...NFCCC). , Port Vila, Van...
(Date:11/26/2009)...ion of ultrasmall transistors and more powerful co...ucting nanowires are closer to reality after a key...y and the University of California at Los Angeles....nowires with layers of different materials that ar...critical requirement for making efficient transist...
Breaking Biology Technology:FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3
...a more proactive approach to collection and..., India and WESTBOROUGH, Mass., June 26 /PRNewswir...E: SAY ), a leading global consulting,and informa... that it has,formed an alliance with Sciformix Cor...Knowledge Process Outsourcing (KPO) company, to de...
...ngress by sepsis thought ...tCall/ - Spectral Diagnostics Inc.,(TSX: SDI) toda...ates the,combined clinical effectiveness of its En...red diagnostic for the measurement of endotoxin, t... and to guide endotoxin,reducing strategies, such ...
...ed a signature for water inside single-walled carb... structured and how it moves within these tiny cha...able to get a snapshot of the water inside the car...SWCNTs) offer the potential to act as a unique nan...rated extremely fast flow in these channels, it is...
Other Biology Technology:Satyam Forms Partnership with Sciformix to Provide Comprehensive Drug Safety Management 2Satyam Forms Partnership with Sciformix to Provide Comprehensive Drug Safety Management 3Satyam Forms Partnership with Sciformix to Provide Comprehensive Drug Safety Management 4Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics 2LLNL researchers peer into water in carbon nanotubes 2
Ready-To-Go T4 DNA Ligase from GE Healthcare, formerly Amersham Biosciences
...olution is a comprehensive suite of advanced stati...lly designed to reliably extract biological signal...c studies containing thousands of samples, Partek ...ll analyze large data sets on a personal computer....
Protein Conjugation Services from ARVYS Proteins, Inc.
SYBR Green I Nucleic Acid Gel Stain from Roche Applied Science
Biology Products: